The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Rachel Black(The University of Sydney), William G Dixon(Manchester Academic Health Science Centre), Catherine Hill(Royal Adelaide Hospital), Susan Lester(Queen Elizabeth Hospital)
Cited by 50
Related Papers
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
|Annals of the Rheumatic Diseases|2009|708
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|584
Prevalence, Deaths, and Disability‐Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990–2017
|Arthritis & Rheumatology|2020|395
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force
|Annals of the Rheumatic Diseases|2016|331
A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis
|Arthritis Research & Therapy|2015|116